Receptor pharmacology of calcium entry blocking agents
- 1 January 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (2), A9-A17
- https://doi.org/10.1016/0002-9149(87)90170-6
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- 1,4-Dlhydropyridines as tools in the study of Ca2+ channelsTrends in Neurosciences, 1985
- Calcium-Antagonist DrugsNew England Journal of Medicine, 1985
- Stereoselectivity at the Calcium ChannelJournal of Cardiovascular Pharmacology, 1985
- Effects of dihydropyridine calcium channel modulators in the heart: Pharmacological and radioligand binding correlationsBiochemical and Biophysical Research Communications, 1984
- The calcium agonist Bay K 8644 stimulates secretion from a pituitary cell lineBiochemical and Biophysical Research Communications, 1984
- Diltiazem Prophylaxis in Refractory MigraineNew England Journal of Medicine, 1984
- Calcium antagonists: A new class of drugsPharmacology & Therapeutics, 1983
- Clinical applications of slow channel blocking compoundsPharmacology & Therapeutics, 1983
- Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazemBiochemical and Biophysical Research Communications, 1982
- Ligand partitioning into membranes: Its significance in determining KM and KS values for cytochrome P‐450 and other membrane bound receptors and enzymesFEBS Letters, 1976